Patents by Inventor Ascher Shmulewitz

Ascher Shmulewitz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11382747
    Abstract: A differential pressure regulating device is provided for controlling in-vivo pressure in a body, particular in a heart. The device may include a shunt being positioned between two or more lumens in a body, to enable fluids to flow between the lumens, and an adjustable flow regulation mechanism being configured to selectively cover an opening of the shunt to regulate the flow of fluid through the shunt in relation to a pressure difference between the body lumens. In some embodiments, a control mechanism coupled to the adjustable flow regulation mechanism may be provided to remotely activate the adjustable flow regulation mechanism.
    Type: Grant
    Filed: March 4, 2022
    Date of Patent: July 12, 2022
    Assignee: V-Wave, Ltd.
    Inventors: Dan Rottenberg, Ori J. Braun, Avraham Aba Zakay, Ascher Shmulewitz, Yoram Rozy, Gad Keren
  • Publication number: 20220211647
    Abstract: The present disclosure provides pharmaceutical compositions and methods for treating paracetamol amenable conditions, such as pain and fever. The pharmaceutical compositions comprise certain combinations of derivatives of 4-Aminophenols and N-acylethanolamines. Also disclosed are methods and kits for treating or minimizing paracetamol amenable conditions.
    Type: Application
    Filed: April 22, 2020
    Publication date: July 7, 2022
    Applicant: SCISPARC LTD.
    Inventors: Ascher SHMULEWITZ, Adi ZULOFF-SHANI, Ephraim BRENER
  • Publication number: 20220183838
    Abstract: A differential pressure regulating device is provided for controlling in-vivo pressure in a body, particular in a heart. The device may include a shunt being positioned between two or more lumens in a body, to enable fluids to flow between the lumens, and an adjustable flow regulation mechanism being configured to selectively cover an opening of the shunt to regulate the flow of fluid through the shunt in relation to a pressure difference between the body lumens. In some embodiments, a control mechanism coupled to the adjustable flow regulation mechanism may be provided to remotely activate the adjustable flow regulation mechanism.
    Type: Application
    Filed: March 4, 2022
    Publication date: June 16, 2022
    Applicant: V-Wave Ltd.
    Inventors: Dan ROTTENBERG, Ori J. BRAUN, Avraham ABA ZAKAY, Ascher SHMULEWITZ, Yoram ROZY, Gad KEREN
  • Publication number: 20220071949
    Abstract: The present invention provides pharmaceutical compositions comprising cannabinoids and N-acylethanolamines, and methods for their use in preventing and treating a variety of cannabinoid-treatable conditions.
    Type: Application
    Filed: November 12, 2021
    Publication date: March 10, 2022
    Applicant: SciSparc Ltd.
    Inventors: Ephraim Brener, Elran Haber, Ascher Shmulewitz
  • Publication number: 20220071948
    Abstract: The present invention provides pharmaceutical compositions comprising cannabinoids and N-acylethanolamines, and methods for their use in preventing and treating a variety of cannabinoid-treatable conditions.
    Type: Application
    Filed: November 12, 2021
    Publication date: March 10, 2022
    Applicant: SciSparc Ltd.
    Inventors: Ephraim Brener, Elran Haber, Ascher Shmulewitz
  • Patent number: 11266501
    Abstract: A differential pressure regulating device is provided for controlling in-vivo pressure in a body, and in particularly in a heart. The device may include a shunt being positioned between two or more lumens in a body, to enable fluids to flow between the lumens, and an adjustable flow regulation mechanism being configured to selectively cover an opening of the shunt, to regulate the flow of fluid through the shunt in relation to a pressure difference between the body lumens. In some embodiments a control mechanism coupled to the adjustable flow regulation mechanism may be provided, to remotely activate the adjustable flow regulation mechanism.
    Type: Grant
    Filed: November 1, 2019
    Date of Patent: March 8, 2022
    Assignee: V-Wave Ltd.
    Inventors: Dan Rottenberg, Ori J. Braun, Avraham Aba Zakay, Ascher Shmulewitz, Yoram Rozy, Gad Keren
  • Patent number: 11234956
    Abstract: The present invention provides pharmaceutical compositions comprising cannabinoids and N-acylethanolamines, and methods for their use in preventing and treating a variety of cannabinoid-treatable conditions.
    Type: Grant
    Filed: April 19, 2016
    Date of Patent: February 1, 2022
    Assignee: SciSparc Ltd.
    Inventors: Ascher Shmulewitz, Elran Haber, Ephraim Brener
  • Patent number: 11207290
    Abstract: The present invention provides pharmaceutical compositions comprising cannabinoids and N-acylethanolamines, and methods for their use in preventing and treating a variety of cannabinoid-treatable conditions.
    Type: Grant
    Filed: August 30, 2019
    Date of Patent: December 28, 2021
    Assignee: SciSparc Ltd.
    Inventors: Ephraim Brener, Elran Haber, Ascher Shmulewitz
  • Publication number: 20210393577
    Abstract: The present invention provides pharmaceutical compositions comprising cannabinoids and N-acylethanolamines, and methods for their use in preventing and treating a variety of cannabinoid-treatable conditions.
    Type: Application
    Filed: August 27, 2021
    Publication date: December 23, 2021
    Applicant: SciSparc Ltd.
    Inventors: Ascher SHMULEWITZ, Elran HABER, Ephraim BRENER
  • Patent number: 11197845
    Abstract: The present invention provides pharmaceutical compositions comprising cannabinoids and N-acylethanolamines, and methods for their use in preventing and treating a variety of cannabinoid-treatable conditions.
    Type: Grant
    Filed: October 10, 2019
    Date of Patent: December 14, 2021
    Assignee: SciSparc Ltd.
    Inventors: Ephraim Brener, Elran Haber, Ascher Shmulewitz
  • Publication number: 20210177779
    Abstract: The present invention provides pharmaceutical compositions comprising opioids and N-acylethanolamines, and methods for their use in preventing and treating a variety of opioid-responsive conditions and opioid-related side-effects.
    Type: Application
    Filed: November 27, 2020
    Publication date: June 17, 2021
    Applicant: SciSparc Ltd.
    Inventors: Ascher SHMULEWITZ, Elran HABER, Ephraim BRENER
  • Publication number: 20210154012
    Abstract: A differential pressure regulating device is provided for controlling in-vivo pressure in a body, and in particularly in a heart. The device may include a shunt being positioned between two or more lumens in a body, to enable fluids to flow between the lumens, and an adjustable flow regulation mechanism being configured to selectively cover an opening of the shunt, to regulate the flow of fluid through the shunt in relation to a pressure difference between the body lumens. In some embodiments a control mechanism coupled to the adjustable flow regulation mechanism may be provided, to remotely activate the adjustable flow regulation mechanism.
    Type: Application
    Filed: February 3, 2021
    Publication date: May 27, 2021
    Applicant: V-Wave Ltd.
    Inventors: Dan ROTTENBERG, Ori J. BRAUN, Avraham ABA ZAKAY, Ascher SHMULEWITZ, Yoram ROZY, Gad KEREN
  • Publication number: 20210093652
    Abstract: Disclosed herein are pharmaceutical compositions comprising at least one anti-bacterial and at least one cannabinoid and methods of use in treating or preventing bacterial infection or biofilm in a subject in need thereof.
    Type: Application
    Filed: June 9, 2020
    Publication date: April 1, 2021
    Applicant: THERAPIX BIOSCIENCES LTD.
    Inventors: Ephraim Brener, Elran Haber, Adi Zuloff-Shani, Ascher Shmulewitz
  • Publication number: 20210051975
    Abstract: In embodiments, the present invention is a mayonnaise emulsified food product that includes 60 wt % to 80 wt % of oil, based on a total weight of the mayonnaise emulsified food product, 10 wt % to 30 wt % of water, based on the total weight of the mayonnaise emulsified food product, wherein the oil and the water form an emulsion, 1 wt % to 5 wt % chickpea protein product, based on the total weight of the mayonnaise emulsified food product, where the chickpea protein product comprises at least 60 wt % protein based on a total weight of the chickpea protein product, where the chickpea protein product is an emulsifier, and optionally, at least one of vinegar, salt, lemon concentrate, or sugar.
    Type: Application
    Filed: December 28, 2017
    Publication date: February 25, 2021
    Inventors: Ascher SHMULEWITZ, Gil DE PICCIOTTO, Nitzan NATANI BEN CHAIM
  • Patent number: 10912645
    Abstract: A differential pressure regulating device is provided for controlling in-vivo pressure in a body, and in particularly in a heart. The device may include a shunt being positioned between two or more lumens in a body, to enable fluids to flow between the lumens, and an adjustable flow regulation mechanism being configured to selectively cover an opening of the shunt, to regulate the flow of fluid through the shunt in relation to a pressure difference between the body lumens. In some embodiments a control mechanism coupled to the adjustable flow regulation mechanism may be provided, to remotely activate the adjustable flow regulation mechanism.
    Type: Grant
    Filed: May 19, 2020
    Date of Patent: February 9, 2021
    Assignee: V-Wave Ltd.
    Inventors: Dan Rottenberg, Ori J. Braun, Avraham Aba Zakay, Ascher Shmulewitz, Yoram Rozy, Gad Keren
  • Publication number: 20200276016
    Abstract: A differential pressure regulating device is provided for controlling in-vivo pressure in a body, and in particularly in a heart. The device may include a shunt being positioned between two or more lumens in a body, to enable fluids to flow between the lumens, and an adjustable flow regulation mechanism being configured to selectively cover an opening of the shunt, to regulate the flow of fluid through the shunt in relation to a pressure difference between the body lumens. In some embodiments a control mechanism coupled to the adjustable flow regulation mechanism may be provided, to remotely activate the adjustable flow regulation mechanism.
    Type: Application
    Filed: May 19, 2020
    Publication date: September 3, 2020
    Applicant: V-Wave Ltd.
    Inventors: Dan ROTTENBERG, Ori J. BRAUN, Avraham ABA ZAKAY, Ascher SHMULEWITZ, Yoram ROZY, Gad KEREN
  • Publication number: 20200261705
    Abstract: A device for regulating blood pressure in a heart chamber is provided. The device includes a shunt positionable within a septum of the heart. The shunt is designed for enabling blood flow between a loft heart chamber and a right heart chamber, wherein the flow rate capacity of the device is mostly a function of pressure in the left heart chamber.
    Type: Application
    Filed: May 4, 2020
    Publication date: August 20, 2020
    Applicant: V-Wave Ltd.
    Inventors: Yaacov NITZAN, Boaz HARARI, Ascher SHMULEWITZ, Tovy SIVAN
  • Patent number: 10639459
    Abstract: A device for regulating blood pressure in a heart chamber is provided. The device includes a shunt positionable within a septum of the heart. The shunt is designed for enabling blood flow between a left heart chamber and a right heart chamber, wherein the flow rate capacity of the device is mostly a function of pressure in the left heart chamber.
    Type: Grant
    Filed: July 14, 2017
    Date of Patent: May 5, 2020
    Assignee: V-Wave Ltd.
    Inventors: Yaacov Nitzan, Boaz Harari, Ascher Shmulewitz, Tovy Sivan
  • Publication number: 20200060825
    Abstract: A differential pressure regulating device is provided for controlling in-vivo pressure in a body, and in particularly in a heart. The device may include a shunt being positioned between two or more lumens in a body, to enable fluids to flow between the lumens, and an adjustable flow regulation mechanism being configured to selectively cover an opening of the shunt, to regulate the flow of fluid through the shunt in relation to a pressure difference between the body lumens. In some embodiments a control mechanism coupled to the adjustable flow regulation mechanism may be provided, to remotely activate the adjustable flow regulation mechanism.
    Type: Application
    Filed: November 1, 2019
    Publication date: February 27, 2020
    Applicant: V-Wave Ltd.
    Inventors: Dan ROTTENBERG, Ori J. BRAUN, Avraham ABA ZAKAY, Ascher SHMULEWITZ, Yoram ROZY, Gad KEREN
  • Publication number: 20200038367
    Abstract: The present invention provides pharmaceutical compositions comprising cannabinoids and N-acylethanolamines, and methods for their use in preventing and treating a variety of cannabinoid-treatable conditions.
    Type: Application
    Filed: October 10, 2019
    Publication date: February 6, 2020
    Applicant: THERAPIX BIOSCIENCES, LTD.
    Inventors: Ephraim Brener, Elran Haber, Ascher Shmulewitz